课题基金 / 基金详情

Arylhydrocarbon receptor in resistance to listeriosis

Arylhydrocarbon receptor in resistance to listeriosis
芳基烃受体抵抗李斯特菌病
批准号:
7055243
负责人:
CHARLES Joseph CZUPRYNSKI
金额:
$17.76万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2008-04-30

项目摘要

项目成果

CHARLES Joseph CZUPRYNSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Listeriosis is an important food borne disease that causes approximately 2,500 cases of serious illness and as many as 500 deaths per year in the United States. Resistance to listedosis requires both innate and adaptive immune responses, with the former being dependent on release of the inflammatory cytokine TNF-alpha and the rapid mobilization of granulocytes and mononuclear phagocytes to sites of infection. The aryl hydrocarbon receptor (AhR) is a highly conserved member of the basic loop helix-PAS protein family. In vertebrates, it regulates a powerful signaling system when it is activated by environmental toxicants such as polychlorinated hydrocarbons (e.g. dioxin) and polycyclic aromatic hydrocarbons (e.g. benzo[a]pyrene). In invertebrates the AhR is involved in environmental sensing, regulation of biological clocks and normal development, and it retains some of these functions within vertebrates. Activation of the AhR can have a deleterious effect on various aspects of the immune system, including host defense against subsequent microbial infection. However, AhR activation also leads to release of TNF-alpha that is responsible for some of its biological effects. We have obtained exciting and provocative preliminary data indicating that AhR null mice are less resistant to experimental listeriosis than their wild type counterparts. The overall goal of this project is to understand how the AhR influences resistance to L. monocytogenes infection. The central hypothesis is that the AhR is required for optimal development and expression of innate immunity against a primary L. monocytogenes infection, and that this involves AhR dependent release of TNF-alpha. The specific aims of the proposal are as follows: 1) Define the requirement of the AhR for resistance to listeriosis in mice; 2) Determine whether the AhR influences the survival and multiplication of L. monocytogenes in hepatocytes; and 3) Investigate the effects of the AhR on the anti-listerial activity of granulocytes and macrophages. The role of TNF-alpha in the responses observed in all 3 aims will be determined. At the completion of this study, we will have novel and important new insights into the participation of the AhR in innate immunity against L. monocytogenes infection. These studies may identify potential new targets for enhancing innate immunity against listeriosis, perhaps by administration of AhR agonists (flavenoids, etc.), that signal through the AhR without triggering the adverse events that follow binding of environmental toxicants.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Flavonoid treatment of murine macrophages does not alter ingestion or intracellular survival of Listeria monocytogenes.
类黄酮治疗小鼠巨噬细胞不会改变单核细胞增生李斯特氏菌的摄入或细胞内存活。
DOI: 10.1080/08923970801946873
发表时间: 2008
期刊: Immunopharmacology and immunotoxicology
影响因子: 3.3
作者: [Berryman,Lyndsey, Czuprynski,CharlesJ]
通讯作者: Czuprynski,CharlesJ
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
  • 批准号:
    8386272
  • 项目类别:
  • 资助金额:
    $18.81万
  • 财政年份:
    2012
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
  • 批准号:
    8518098
  • 项目类别:
  • 资助金额:
    $21.29万
  • 财政年份:
    2012
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Comparative Biomedical Sciences Training Program
  • 批准号:
    8266731
  • 项目类别:
  • 资助金额:
    $30.76万
  • 财政年份:
    2007
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Comparative Biomedical Sciences Training Program
  • 批准号:
    7456455
  • 项目类别:
  • 资助金额:
    $22.09万
  • 财政年份:
    2007
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
国内基金
海外基金
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
  • 批准号:
    82372202
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯旭敏
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
  • 批准号:
    82370797
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陶弢
  • 依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82370865
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    黄哲
  • 依托单位: